Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies
暂无分享,去创建一个
H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | E. Freireich | M. Talpaz | M. Rosenblum | S. Faderl